Page last updated: 2024-12-06

2-hydroxynicotinic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2-Hydroxynicotinic acid, also known as 6-hydroxypyridine-2-carboxylic acid, is a naturally occurring compound found in various plants. It exhibits a wide range of biological activities, including anti-inflammatory, antioxidant, and anti-cancer properties. Its synthesis can be achieved through various methods, such as microbial fermentation or chemical synthesis. The compound has garnered significant attention for its potential therapeutic applications. Studies have investigated its effectiveness in treating inflammatory conditions, oxidative stress-related disorders, and even certain types of cancer. Further research is ongoing to understand its mechanism of action and optimize its potential for clinical use.'

Cross-References

ID SourceID
PubMed CID69114
CHEMBL ID53297
CHEBI ID166572
SCHEMBL ID107538
MeSH IDM0058489

Synonyms (62)

Synonym
AC-3028
2-oxo-1h-pyridine-3-carboxylic acid
CHEBI:166572
F2191-0002
609-71-2
nsc226152
nsc-226152
2-hydroxynicotinic acid ,
OPREA1_483223
2-hydroxypyridine-3-carboxylic acid
STK317943
STK317942
2-oxo-1,2-dihydropyridine-3-carboxylic acid
2-hydroxypyridine-3-carboxylic acid, 98%
AKOS000103822
AKOS000103823
ES6 ,
CHEMBL53297
ueyqjqvbuvaelz-uhfffaoysa-
2-hydroxy-3-pyridinecarboxylic acid
H0795
A8475
BBL001459
BBL009636
1,2-dihydro-2-oxonicotinic acid
nsc 226152
tmq68q9ba3 ,
einecs 210-198-2
1,2-dihydro-2-oxo-3-pyridinecarboxylic acid
unii-tmq68q9ba3
FT-0602428
PS-5332
AM20070024
AB01020
3-carboxy-2-pyridone
nicotinic acid, 1,2-dihydro-2-oxo-
2-hydroxy-3-carboxypyridine
SCHEMBL107538
2-hydroxy nicotinic acid
oxopyridine-3-carboxylic acid
2-hydroxy-nicotinic acid
3-pyridinecarboxylic acid, 1,2-dihydro-2-oxo-
W-105218
AI-942/25034173
mfcd00010100
DTXSID20209735
F2190-0004
2-hydroxynicotinic acid, purum, >=98.0% (t)
2-oxo-1,2-dihydropyridine-3-carboxylic acid, aldrichcpr
2-ohnich
SY003611
2-oxopyridine-3-carboxylic acid
CS-W018547
2-oxo-1,2-dihydro-3-pyridinecarboxylic acid
2-odhpca
EN300-17753
2-hydroxynictinic acid
mfcd01859877
Q27290030
AB7337
2-oxo-1,2-dihydropyridine-3-carboxylicacid
Z57012260
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
pyridinesAny organonitrogen heterocyclic compound based on a pyridine skeleton and its substituted derivatives.
aromatic carboxylic acidAny carboxylic acid in which the carboxy group is directly bonded to an aromatic ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Nicotinate phosphoribosyltransferaseHomo sapiens (human)Ki0.00020.00000.00060.0019AID1618606
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
response to oxidative stressNicotinate phosphoribosyltransferaseHomo sapiens (human)
NAD salvageNicotinate phosphoribosyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (4)

Processvia Protein(s)Taxonomy
nicotinate phosphoribosyltransferase activityNicotinate phosphoribosyltransferaseHomo sapiens (human)
protein bindingNicotinate phosphoribosyltransferaseHomo sapiens (human)
transferase activityNicotinate phosphoribosyltransferaseHomo sapiens (human)
metal ion bindingNicotinate phosphoribosyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
extracellular regionNicotinate phosphoribosyltransferaseHomo sapiens (human)
cytosolNicotinate phosphoribosyltransferaseHomo sapiens (human)
azurophil granule lumenNicotinate phosphoribosyltransferaseHomo sapiens (human)
extracellular exosomeNicotinate phosphoribosyltransferaseHomo sapiens (human)
cytosolNicotinate phosphoribosyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID172388Hypoglycemic activity in blood glucose at 2 hr (treated) in the 18-h fasted normal rat at a dose of 100 mg/kg1985Journal of medicinal chemistry, Dec, Volume: 28, Issue:12
1,2-Dihydro-2-oxo-6-(2,2-dimethylpropyl)-3-pyridinecarboxylic acid, analogues, and derivatives. A new class of oral hypoglycemic agents.
AID1132607Drug metabolism in po dosed dog urine assessed as 1-(beta-D-ribofuranosyl)-2-oxo-nicotinic acid level1978Journal of medicinal chemistry, May, Volume: 21, Issue:5
Synthesis and antiinflammatory activity of 6-oxo-1-(beta-D-ribofuranosyl)nocotinic acid and related derivatives.
AID1132606Drug metabolism in po dosed rat urine assessed as 1-(beta-D-ribofuranosyl)-2-oxo-nicotinic acid level1978Journal of medicinal chemistry, May, Volume: 21, Issue:5
Synthesis and antiinflammatory activity of 6-oxo-1-(beta-D-ribofuranosyl)nocotinic acid and related derivatives.
AID172385Hypoglycemic activity in blood glucose at 2 hr (positive control) in the 18-h fasted normal rat1985Journal of medicinal chemistry, Dec, Volume: 28, Issue:12
1,2-Dihydro-2-oxo-6-(2,2-dimethylpropyl)-3-pyridinecarboxylic acid, analogues, and derivatives. A new class of oral hypoglycemic agents.
AID1453183Binding affinity to CK2alpha (unknown origin) assessed as change in melting temperature by thermal shift assay2017Bioorganic & medicinal chemistry, 07-01, Volume: 25, Issue:13
A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066.
AID172386Hypoglycemic activity in blood glucose at 2 hr (positive control) in the fasted-refed rat1985Journal of medicinal chemistry, Dec, Volume: 28, Issue:12
1,2-Dihydro-2-oxo-6-(2,2-dimethylpropyl)-3-pyridinecarboxylic acid, analogues, and derivatives. A new class of oral hypoglycemic agents.
AID172389Hypoglycemic activity in blood glucose at 2 hr (treated) in the fasted-refed rat1985Journal of medicinal chemistry, Dec, Volume: 28, Issue:12
1,2-Dihydro-2-oxo-6-(2,2-dimethylpropyl)-3-pyridinecarboxylic acid, analogues, and derivatives. A new class of oral hypoglycemic agents.
AID187292Hypoglycemic activity in the 18-h fasted normal rat with respect to 1-butyl-3-(p-tolylsulphonyl)urea1985Journal of medicinal chemistry, Dec, Volume: 28, Issue:12
1,2-Dihydro-2-oxo-6-(2,2-dimethylpropyl)-3-pyridinecarboxylic acid, analogues, and derivatives. A new class of oral hypoglycemic agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.66 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.21 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]